What Do Drug Monopolies Cost Consumers in Developing Countries?
Federal Reserve Bank of New York
December 1, 2011
FRB of New York Staff Report No. 530
This paper quantifies the effects of drug monopolies and low per-capita income on pharmaceutical prices in developing economies using the example of the antiretroviral drugs (ARVs) used to treat HIV.
Number of Pages in PDF File: 11
Keywords: Intellectual property rights, international price discrimination, TRIPS agreement, pharmaceutical industry, markups
JEL Classification: D4, F13, L1, L65, O34working papers series
Date posted: December 24, 2011
© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.
This page was processed by apollo1 in 0.265 seconds